Synapse

← Joseph B. Muhlestein

Papers by Joseph B. Muhlestein

Page 1 · newest first

  1. Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery DiseaseCirculation · 2000
  2. Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?Journal of the American College of Cardiology · 2005
  3. Increased incidence of Chlamydiaspecies within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular diseaseJournal of the American College of Cardiology · 1996
  4. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapseEuropean Heart Journal · 2022
  5. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trialEuropean Heart Journal · 2020
  6. Weight loss-independent changes in human growth hormone during water-only fasting: a secondary evaluation of a randomized controlled trialFrontiers in Endocrinology · 2025
  7. Insulin resistance reduction, intermittent fasting, and human growth hormone: secondary analysis of a randomized trialnpj Metabolic Health and Disease · 2024
  8. Clinicoeconomic burden among heart failure patients with severely reduced ejection fraction after hospital admission: HF-RESTOREEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2024
  9. International consensus on fasting terminologyCell Metabolism · 2024
  10. Weight Loss-Independent Changes in Human Growth Hormone During Water-Only Fasting: A Secondary Evaluation of a Randomized Controlled Trial2024
  11. Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US SampleJournal of Clinical Medicine · 2024
  12. Impact of Active vs Passive Statin Selection for Primary PreventionJACC Advances · 2023
  13. Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trialInternational Journal of Cardiology Cardiovascular Risk and Prevention · 2023
  14. Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular eventsFrontiers in Cardiovascular Medicine · 2023
  15. Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATEFrontiers in Cardiovascular Medicine · 2023
  16. Impact of Statin Therapy in Heart Failure PatientsJACC Advances · 2023
  17. Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare ExperienceJournal of Clinical Medicine · 2023
  18. Multimarkers of metabolic malnutrition and inflammation and their association with mortality risk in cardiac catheterisation patients: a prospective, longitudinal, observational, cohort studyThe Lancet Healthy Longevity · 2023
  19. Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare ExperienceJournal of Clinical Medicine · 2022
  20. Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19IJC Heart & Vasculature · 2022
  21. Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)Journal of Arrhythmia · 2022
  22. Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registryBMJ Nutrition Prevention & Health · 2022
  23. Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysisBMC Family Practice · 2022
  24. Association of Periodic Fasting with Lower Severity of COVID-19 Outcomes in the SARS-CoV-2 Pre-Vaccine Era: An Observational Cohort from the INSPIRE Registry2022
  25. Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohortBMJ Open · 2022
  26. Preferential Metabolic Improvement by Intermittent Fasting in People with Elevated Baseline Red Cell Distribution Width: A Secondary Analysis of the WONDERFUL Randomized Controlled TrialNutrients · 2021
  27. Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled TrialAmerican Heart Journal · 2021
  28. The history and geographic distribution of a KCNQ1 atrial fibrillation risk alleleNature Communications · 2021
  29. A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigoSHILAP Revista de lepidopterología · 2021
  30. Absent or Mild Coronary Calcium Predicts Low-Risk Stress Test Results and Outcomes in Patients Considered for Flecainide TherapyJournal of Cardiovascular Pharmacology and Therapeutics · 2021
  31. High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES studyEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2021
  32. Vitamin D supplementation protects against reductions in plasma 25‐hydroxyvitamin D induced by open‐heart surgery: Assess‐d trialPhysiological Reports · 2021
  33. E valuation of T R eatment With A ngiotensin C onverting E nzyme Inhibitors and the R isk of Lung Cancer: ERACER—An Observational Cohort StudyJournal of Cardiovascular Pharmacology and Therapeutics · 2021
  34. Frequency and Clinical Impact of Hyperkalaemia Within a Large, Modern, Real-World Heart Failure PopulationESC Heart Failure · 2020
  35. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim resultsCardiovascular Research · 2020
  36. Patterns of cardiac dysfunction after carbon monoxide poisoningUndersea and Hyperbaric Medicine · 2020
  37. Absence of Coronary Artery Calcium During Positron Emission Tomography Stress Testing in Patients Without Known Coronary Artery Disease Identifies Individuals With Very Low Risk of Cardiac EventsCirculation Cardiovascular Imaging · 2020
  38. Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 StudiesCardiology and Therapy · 2019
  39. Pilot Study of Novel Intermittent Fasting Effects on Metabolomic and Trimethylamine N-oxide Changes During 24-hour Water-Only Fasting in the FEELGOOD TrialNutrients · 2019
  40. Improving CHA₂DS₂-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillationOpen Heart · 2018
  41. Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT eraJCI Insight · 2018
  42. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE studyClinical Cardiology · 2018
  43. The association of depression at any time to the risk of death following coronary artery disease diagnosisEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2017
  44. The association of antidepressant and statin use with death and incident cardiovascular disease varies by depression severityPsychology Health & Medicine · 2017
  45. Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulationTherapeutic Advances in Cardiovascular Disease · 2016
  46. Short‐Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST‐Segment Elevation Acute Coronary EventsSHILAP Revista de lepidopterología · 2015
  47. The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart StudyEuropean Journal of Preventive Cardiology · 2015
  48. Pulmonary-Specific Intermountain Risk Score Predicts All-Cause Mortality via Spirometry, the Red Cell Distribution Width, and Other Laboratory ParametersRespiratory Care · 2015
  49. Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative StudyCardiology Research and Practice · 2015
  50. Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High-Risk Patients With DiabetesJAMA · 2014